Stay updated on Trametinib and Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Trametinib and Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:19:32.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, replacing the previously visible trial information with an access-restricted error screen. This change indicates the trial record is currently unavailable due to an access issue.
    Difference
    19%
    Check dated 2026-09-21T20:28:34.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a newer version of the page has been published, with no visible changes to the study content.
    Difference
    0.1%
    Check dated 2026-08-31T17:49:14.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5, indicating an updated publication version. This reflects a minor update to the page metadata rather than changes to the trial details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-10T12:33:07.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision v3.6.4 was added and Revision v3.6.3 was removed. This represents a minor update to the page's revision history.
    Difference
    0.1%
    Check dated 2026-07-27T06:35:10.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Mid-July 2026 update timestamps were added to the study record and January 2026 timestamps were removed. This reflects a refresh of the record's revision history rather than changes to the study data.
    Difference
    0.2%
    Check dated 2026-07-20T01:33:11.000Z thumbnail image

Stay in the know with updates to Trametinib and Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Trametinib and Pembrolizumab in NSCLC Clinical Trial page.